{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:05:51Z","timestamp":1787763951121,"version":"build-2784847793"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","award":["4719"],"award-info":[{"award-number":["4719"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07905-9","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:04:15Z","timestamp":1777975455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8+ T Cells"],"prefix":"10.1186","volume":"24","author":[{"given":"Amir Saeid","family":"Mahdavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Khosravian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Ghatrehsamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"7905_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.NPR.0000000000000172","volume":"49","author":"SC Davis","year":"2024","unstructured":"Davis SC, Snyder E. Factors impacting quality of life for breast cancer survivors. The Nurse Practitioner. 2024;49:17\u201323.","journal-title":"The Nurse Practitioner"},{"key":"7905_CR2","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.esmoop.2022.100409","volume":"7","author":"F Miglietta","year":"2022","unstructured":"Miglietta F, Bottosso M, Griguolo G, Dieci M, Guarneri V. Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival. ESMO open. 2022;7:100409.","journal-title":"ESMO open"},{"key":"7905_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"7905_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/bmm.12.114","volume":"7","author":"T Hyslop","year":"2013","unstructured":"Hyslop T, Michael Y, Avery T, Rui H. Population and target considerations for triple-negative breast cancer clinical trials. Biomark Med. 2013;7:11\u201321.","journal-title":"Biomark Med"},{"key":"7905_CR5","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.3390\/cancers13153739","volume":"13","author":"F Hossain","year":"2021","unstructured":"Hossain F, Majumder S, David J, Miele L. Precision medicine and triple-negative breast cancer: current landscape and future directions. Cancers. 2021;13:3739.","journal-title":"Cancers"},{"key":"7905_CR6","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.critrevonc.2024.104351","volume":"197","author":"MM Khan","year":"2024","unstructured":"Khan MM, Yalamarty SSK, Rajmalani BA, Filipczak N, Torchilin VP. Recent strategies to overcome breast cancer resistance. Crit Rev Oncol\/Hematol. 2024;197:104351.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"7905_CR7","doi-asserted-by":"publisher","first-page":"108800","DOI":"10.1016\/j.biopha.2019.108800","volume":"114","author":"X Ji","year":"2019","unstructured":"Ji X, Lu Y, Tian H, Meng X, Wei M, Cho WC. Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother. 2019;114:108800.","journal-title":"Biomed Pharmacother"},{"key":"7905_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2024.06.003","volume":"372","author":"J Mondal","year":"2024","unstructured":"Mondal J, Chakraborty K, Bunggulawa EJ, An JM, Revuri V, Nurunnabi M, Lee Y-K. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment. J Controlled Release. 2024;372:1\u201330.","journal-title":"J Controlled Release"},{"key":"7905_CR9","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/j.clbc.2020.06.011","volume":"21","author":"SL Goff","year":"2021","unstructured":"Goff SL, Danforth DN. The role of immune cells in breast tissue and immunotherapy for the treatment of breast cancer. Clin Breast Cancer. 2021;21:e63\u201373.","journal-title":"Clin Breast Cancer"},{"key":"7905_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","volume":"9","author":"V Debien","year":"2023","unstructured":"Debien V, De Caluw\u00e9 A, Wang X, Piccart-Gebhart M, Tuohy VK, Romano E, Buisseret L. Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ breast cancer. 2023;9:7.","journal-title":"NPJ breast cancer"},{"key":"7905_CR11","doi-asserted-by":"publisher","first-page":"1302587","DOI":"10.3389\/fimmu.2024.1302587","volume":"15","author":"T Akinsipe","year":"2024","unstructured":"Akinsipe T, Mohamedelhassan R, Akinpelu A, Pondugula SR, Mistriotis P, Avila LA, Suryawanshi A. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics. Front Immunol. 2024;15:1302587.","journal-title":"Front Immunol"},{"key":"7905_CR12","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.3390\/cancers13164233","volume":"13","author":"JJ Li","year":"2021","unstructured":"Li JJ, Tsang JY, Tse GM. Tumor microenvironment in breast cancer\u2014updates on therapeutic implications and pathologic assessment. Cancers. 2021;13:4233.","journal-title":"Cancers"},{"key":"7905_CR13","doi-asserted-by":"publisher","first-page":"610303","DOI":"10.3389\/fonc.2021.610303","volume":"11","author":"V Salemme","year":"2021","unstructured":"Salemme V, Centonze G, Cavallo F, Defilippi P, Conti L. The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy. Front Oncol. 2021;11:610303.","journal-title":"Front Oncol"},{"key":"7905_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yu D, Qian H, Shi Y, Tao Z. CD8\u2009+\u2009T cell-based cancer immunotherapy. J Translational Med. 2024;22:394.","journal-title":"J Translational Med"},{"key":"7905_CR15","doi-asserted-by":"publisher","first-page":"216043","DOI":"10.1016\/j.canlet.2022.216043","volume":"559","author":"Q Wang","year":"2023","unstructured":"Wang Q, Qin Y, Li B. CD8\u2009+\u2009T cell exhaustion and cancer immunotherapy. Cancer Lett. 2023;559:216043.","journal-title":"Cancer Lett"},{"key":"7905_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-025-06291-y","volume":"23","author":"Y Lin","year":"2025","unstructured":"Lin Y, Song Y, Zhang Y, Li X, Kan L, Han S. New insights on anti-tumor immunity of CD8\u2009+\u2009T cells: cancer stem cells, tumor immune microenvironment and immunotherapy. J Translational Med. 2025;23:341.","journal-title":"J Translational Med"},{"key":"7905_CR17","doi-asserted-by":"publisher","first-page":"1507283","DOI":"10.3389\/fimmu.2024.1507283","volume":"15","author":"H Xie","year":"2024","unstructured":"Xie H, Xi X, Lei T, Liu H, Xia Z. CD8\u2009+\u2009T cell exhaustion in the tumor microenvironment of breast cancer. Front Immunol. 2024;15:1507283.","journal-title":"Front Immunol"},{"key":"7905_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler A, Vignali DA. T cell exhaustion. Annu Rev Immunol. 2024;42:179\u2013206.","journal-title":"Annu Rev Immunol"},{"key":"7905_CR19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/cancers14041078","volume":"14","author":"A Titov","year":"2022","unstructured":"Titov A, Kaminskiy Y, Ganeeva I, Zmievskaya E, Valiullina A, Rakhmatullina A, Petukhov A, Miftakhova R, Rizvanov A, Bulatov E. Knowns and unknowns about CAR-T cell dysfunction. Cancers. 2022;14:1078.","journal-title":"Cancers"},{"key":"7905_CR20","doi-asserted-by":"publisher","first-page":"e0280851","DOI":"10.1371\/journal.pone.0280851","volume":"18","author":"IJ Rodr\u00edguez","year":"2023","unstructured":"Rodr\u00edguez IJ, Bernal-Est\u00e9vez DA, Llano-Le\u00f3n M, Bonilla CE, Parra-L\u00f3pez CA. Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients. PLoS ONE. 2023;18:e0280851.","journal-title":"PLoS ONE"},{"key":"7905_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/med.21727","volume":"41","author":"MA Hossain","year":"2021","unstructured":"Hossain MA, Liu G, Dai B, Si Y, Yang Q, Wazir J, Birnbaumer L, Yang Y. Reinvigorating exhausted CD8\u2009+\u2009cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy. Med Res Rev. 2021;41:156\u2013201.","journal-title":"Med Res Rev"},{"key":"7905_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","volume":"17","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shao Q, Peng G. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment. Cell Mol Immunol. 2020;17:27\u201335.","journal-title":"Cell Mol Immunol"},{"key":"7905_CR23","doi-asserted-by":"publisher","first-page":"1338680","DOI":"10.3389\/fimmu.2024.1338680","volume":"15","author":"M Huang","year":"2024","unstructured":"Huang M, Wang Y, Fang L, Liu C, Feng F, Liu L, Sun C. T cell senescence: a new perspective on immunotherapy in lung cancer. Front Immunol. 2024;15:1338680.","journal-title":"Front Immunol"},{"key":"7905_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00927.x","volume":"236","author":"JM Angelosanto","year":"2010","unstructured":"Angelosanto JM, Wherry EJ. Transcription factor regulation of CD8\u2009+\u2009T-cell memory and exhaustion. Immunol Rev. 2010;236:167\u201375.","journal-title":"Immunol Rev"},{"key":"7905_CR25","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1073\/pnas.1905675116","volume":"116","author":"H Seo","year":"2019","unstructured":"Seo H, Chen J, Gonz\u00e1lez-Avalos E, Samaniego-Castruita D, Das A, Wang YH, L\u00f3pez-Moyado IF, Georges RO, Zhang W, Onodera A. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8\u2009+\u2009T cell exhaustion. Proc Natl Acad Sci. 2019;116:12410\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"7905_CR26","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.114.011195","volume":"130","author":"L Li","year":"2014","unstructured":"Li L, Chen Y, Doan J, Murray J, Molkentin JD, Liu Q. Transforming growth factor \u03b2\u2013activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation. 2014;130:2162\u201372.","journal-title":"Circulation"},{"key":"7905_CR27","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/cdd.2014.123","volume":"21","author":"S Mihaly","year":"2014","unstructured":"Mihaly S, Ninomiya-Tsuji J, Morioka S. TAK1 control of cell death. Cell Death Differ. 2014;21:1667\u201376.","journal-title":"Cell Death Differ"},{"key":"7905_CR28","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jpain.2023.04.011","volume":"24","author":"S Scarneo","year":"2023","unstructured":"Scarneo S, Zhang X, Wang Y, Camacho-Domenech J, Ricano J, Hughes P, Haystead T, Nackley AG. Transforming growth factor-\u03b2-activated kinase 1 (TAK1) mediates chronic pain and cytokine production in mouse models of inflammatory, neuropathic, and primary pain. J pain. 2023;24:1633\u201344.","journal-title":"J pain"},{"key":"7905_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41419-024-06654-1","volume":"15","author":"H Damhofer","year":"2024","unstructured":"Damhofer H, Tatar T, Southgate B, Scarneo S, Agger K, Shlyueva D, Uhrbom L, Morrison GM, Hughes PF, Haystead T. TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death Dis. 2024;15:273.","journal-title":"Cell Death Dis"},{"key":"7905_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.chembiol.2017.07.011","volume":"24","author":"J Totzke","year":"2017","unstructured":"Totzke J, Gurbani D, Raphemot R, Hughes PF, Bodoor K, Carlson DA, Loiselle DR, Bera AK, Eibschutz LS, Perkins MM. Takinib, a selective TAK1 inhibitor, broadens the therapeutic efficacy of TNF-\u03b1 inhibition for cancer and autoimmune disease. Cell Chem biology. 2017;24:1029\u201339. e1027.","journal-title":"Cell Chem biology"},{"key":"7905_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells8020089","volume":"8","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM. Metabolic reprogramming in breast cancer and its therapeutic implications. Cells. 2019;8:89.","journal-title":"Cells"},{"key":"7905_CR32","doi-asserted-by":"publisher","first-page":"e005719","DOI":"10.1136\/jitc-2022-005719","volume":"11","author":"V Finisguerra","year":"2023","unstructured":"Finisguerra V, Dvorakova T, Formenti M, Van Meerbeeck P, Mignion L, Gallez B, Van den Eynde BJ. Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression. J Immunother Cancer. 2023;11:e005719.","journal-title":"J Immunother Cancer"},{"key":"7905_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tifs.2023.03.007","volume":"134","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Arif M, Xu M, Zhang J, Ding Y, Lyu F. Therapeutic values and nutraceutical properties of shiitake mushroom (Lentinula edodes): A review. Trends Food Sci Technol. 2023;134:123\u201335.","journal-title":"Trends Food Sci Technol"},{"key":"7905_CR34","doi-asserted-by":"crossref","unstructured":"Shin MS, Park H-J, Maeda T, Nishioka H, Fujii H, Kang I. The effects of AHCC\u00ae, a standardized extract of cultured Lentinura edodes mycelia, on natural killer and T cells in health and disease: reviews on human and animal studies. Journal of immunology research. 2019:3758576.","DOI":"10.1155\/2019\/3758576"},{"key":"7905_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, \u017d\u00eddek A, Potapenko A. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"7905_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem"},{"key":"7905_CR37","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M. PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res. 2015;43:W443\u20137.","journal-title":"Nucleic Acids Res"},{"key":"7905_CR38","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3389\/fphar.2020.01094","volume":"11","author":"N Cao","year":"2020","unstructured":"Cao N, Lu Y, Liu J, Cai F, Xu H, Chen J, Zhang X, Hua Z-C, Zhuang H. Metformin synergistically enhanced the antitumor activity of celecoxib in human non-small cell lung cancer cells. Front Pharmacol. 2020;11:1094.","journal-title":"Front Pharmacol"},{"key":"7905_CR39","doi-asserted-by":"publisher","first-page":"1266315","DOI":"10.3389\/fimmu.2023.1266315","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Pang C, Zhang J, Peng L, Zhang X, Shi L, Zhang H. Takinib inhibits microglial M1 polarization and oxidative damage after subarachnoid hemorrhage by targeting TAK1-dependent NLRP3 inflammasome signaling pathway. Front Immunol. 2023;14:1266315.","journal-title":"Front Immunol"},{"key":"7905_CR40","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","volume":"4","author":"F Wang","year":"2020","unstructured":"Wang F, Su H, Xu D, Dai W, Zhang W, Wang Z, Anderson CF, Zheng M, Oh R, Wan F. Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel. Nat biomedical Eng. 2020;4:1090\u2013101.","journal-title":"Nat biomedical Eng"},{"key":"7905_CR41","doi-asserted-by":"publisher","first-page":"e10129","DOI":"10.1002\/btm2.10129","volume":"4","author":"A Pusuluri","year":"2019","unstructured":"Pusuluri A, Krishnan V, Wu D, Shields IVCW, Wang LW, Mitragotri S. Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin. Bioeng Translational Med. 2019;4:e10129.","journal-title":"Bioeng Translational Med"},{"key":"7905_CR42","doi-asserted-by":"publisher","first-page":"875872","DOI":"10.3389\/fimmu.2022.875872","volume":"13","author":"H-J Park","year":"2022","unstructured":"Park H-J, Boo S, Park I, Shin MS, Takahashi T, Takanari J, Homma K, Kang I. AHCC\u00ae, a standardized extract of cultured Lentinula edodes mycelia, promotes the anti-tumor effect of dual immune checkpoint blockade effect in murine colon cancer. Front Immunol. 2022;13:875872.","journal-title":"Front Immunol"},{"key":"7905_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/1541-7786.MCR-20-0115","volume":"19","author":"E Kawakita","year":"2021","unstructured":"Kawakita E, Yang F, Kumagai A, Takagaki Y, Kitada M, Yoshitomi Y, Ikeda T, Nakamura Y, Ishigaki Y, Kanasaki K. Metformin mitigates DPP-4 inhibitor-induced breast cancer metastasis via suppression of mTOR signaling. Mol Cancer Res. 2021;19:61\u201373.","journal-title":"Mol Cancer Res"},{"key":"7905_CR44","doi-asserted-by":"crossref","unstructured":"Mir\u00f3 Dom\u00e8nech L, L\u00f3pez J, Guerrero Barrado PE, Mart\u00ednez Bosch N, Manero-Rup\u00e9rez N, Moreno M, Ortiz Duran MR, Llop Escorihuela E, Navarro P. Peracaula Mir\u00f3 R: Sialyltransferase inhibitor Ac53FaxNeu5Ac reverts the malignant phenotype of pancreatic cancer cells, and reduces tumor volume and favors t-cell infiltrates in Mice. 2022.","DOI":"10.3390\/cancers14246133"},{"key":"7905_CR45","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1002\/cpz1.995","volume":"4","author":"SS Oh","year":"2024","unstructured":"Oh SS, Narver HL. Mouse and rat anesthesia and analgesia. Curr protocols. 2024;4:e995.","journal-title":"Curr protocols"},{"key":"7905_CR46","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.3390\/cancers14133171","volume":"14","author":"H Yan","year":"2022","unstructured":"Yan H, Vail ME, Hii L, Guo N, McMurrick PJ, Oliva K, Wilkins S, Saha N, Nikolov DB, Lee F-T. Preferential antibody and drug conjugate targeting of the ADAM10 metalloprotease in tumours. Cancers. 2022;14:3171.","journal-title":"Cancers"},{"key":"7905_CR47","doi-asserted-by":"crossref","unstructured":"Livak KJ. TD <>Schmittgen 2001 analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013\u2009\u2206\u2206CT method. Methods 25 402\u20138.","DOI":"10.1006\/meth.2001.1262"},{"key":"7905_CR48","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.18632\/oncotarget.24483","volume":"9","author":"RA Wolff","year":"2018","unstructured":"Wolff RA, Wang-Gillam A, Alvarez H, Tiriac H, Engle D, Hou S, Groff AF, San Lucas A, Bernard V, Allenson K. Dynamic changes during the treatment of pancreatic cancer. Oncotarget. 2018;9:14764.","journal-title":"Oncotarget"},{"key":"7905_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12964-021-00775-2","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Wang S, Wang N, Zheng Y, Yang B, Wang X, Zhang J, Pan B, Wang Z. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM\/CXCL1-induced Treg differentiation and infiltration. Cell Communication Signal. 2021;19:89.","journal-title":"Cell Communication Signal"},{"key":"7905_CR50","doi-asserted-by":"publisher","first-page":"e003217","DOI":"10.1136\/jitc-2021-003217","volume":"9","author":"F Ma","year":"2021","unstructured":"Ma F, Vayalil J, Lee G, Wang Y, Peng G. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. J Immunother Cancer. 2021;9:e003217.","journal-title":"J Immunother Cancer"},{"key":"7905_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018;33:547\u201362.","journal-title":"Cancer Cell"},{"key":"7905_CR52","doi-asserted-by":"crossref","unstructured":"Roszczyk A, Zych M, Zielniok K, Krata N, Tur\u0142o J, Klimaszewska M, Zago\u017cd\u017con R, Kaleta B. The effect of novel selenopolysaccharide isolated from Lentinula edodes mycelium on human T lymphocytes activation, proliferation, and cytokines synthesis. Biomolecules. 2022;12:1900.","DOI":"10.3390\/biom12121900"},{"key":"7905_CR53","doi-asserted-by":"publisher","first-page":"eaba7791","DOI":"10.1126\/scitranslmed.aba7791","volume":"13","author":"ES Lightcap","year":"2021","unstructured":"Lightcap ES, Yu P, Grossman S, Song K, Khattar M, Xega K, He X, Gavin JM, Imaichi H, Garnsey JJ. A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models. Sci Transl Med. 2021;13:eaba7791.","journal-title":"Sci Transl Med"},{"key":"7905_CR54","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1158\/1078-0432.CCR-24-1004","volume":"30","author":"N Sheng","year":"2024","unstructured":"Sheng N, Shindo K, Ohuchida K, Shinkawa T, Zhang B, Feng H, Yamamoto T, Moriyama T, Ikenaga N, Nakata K. TAK1 promotes an immunosuppressive tumor microenvironment through cancer-associated fibroblast phenotypic conversion in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2024;30:5138\u201353.","journal-title":"Clin Cancer Res"},{"key":"7905_CR55","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.3390\/cancers13092234","volume":"13","author":"D Fenoglio","year":"2021","unstructured":"Fenoglio D, Belgioia L, Parodi A, Missale F, Bacigalupo A, Tarke A, Incandela F, Negrini S, Vecchio S, Altosole T. Development of exhaustion and acquisition of regulatory function by infiltrating CD8\u2009+\u2009CD28\u2013 T lymphocytes dictate clinical outcome in head and neck cancer. Cancers. 2021;13:2234.","journal-title":"Cancers"},{"key":"7905_CR56","first-page":"267","volume":"33","author":"M Sabzevary-Ghahfarokhi","year":"2018","unstructured":"Sabzevary-Ghahfarokhi M, Shirzad H, Rafieian-Kopaei M, Ghatreh-Samani M, Shohan M. The role of inflammatory cytokines in creating T cell exhaustion in cancer. Cancer Biother Radiopharm. 2018;33:267\u201373.","journal-title":"Cancer Biother Radiopharm"},{"key":"7905_CR57","doi-asserted-by":"publisher","first-page":"125037","DOI":"10.1016\/j.ijpharm.2024.125037","volume":"669","author":"M Entezam","year":"2025","unstructured":"Entezam M, Bagheri N, Soltani A, Hosseini SA, Khosravian P, Ferns GA, Ghatrehsamani M. Enhanced antitumor immunity in breast cancer: Synergistic effects of ADAM10\/ADAM17 inhibition, metabolic modulation, and camptothecin-loaded selenium nanoparticles. Int J Pharm. 2025;669:125037.","journal-title":"Int J Pharm"},{"key":"7905_CR58","doi-asserted-by":"publisher","first-page":"109605","DOI":"10.1016\/j.abb.2023.109605","volume":"741","author":"B-W Xie","year":"2023","unstructured":"Xie B-W, Guan B, Chen W, Zhou M, Gu Q, Liu Y, Yan D. Tumor-derived extracellular vesicles delivering TNF-\u03b1 promotes colorectal cancer metastasis via the NF-kB\/LAMB3\/AKT axis by targeting SNAP23. Arch Biochem Biophys. 2023;741:109605.","journal-title":"Arch Biochem Biophys"},{"key":"7905_CR59","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1038\/s41467-017-02358-7","volume":"8","author":"F Bertrand","year":"2017","unstructured":"Bertrand F, Montfort A, Marcheteau E, Imbert C, Gilhodes J, Filleron T, Rochaix P, Andrieu-Abadie N, Levade T, Meyer N. TNF\u03b1 blockade overcomes resistance to anti-PD-1 in experimental melanoma. Nat Commun. 2017;8:2256.","journal-title":"Nat Commun"},{"key":"7905_CR60","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.18632\/oncotarget.27606","volume":"11","author":"SA Scarneo","year":"2020","unstructured":"Scarneo SA, Yang KW, Roques JR, Dai A, Eibschutz LS, Hughes P, Haystead TA. TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades. Oncotarget. 2020;11:1961.","journal-title":"Oncotarget"},{"key":"7905_CR61","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41420-023-01419-9","volume":"9","author":"E-G Sun","year":"2023","unstructured":"Sun E-G, Vijayan V, Park M-R, Yoo KH, Cho S-H, Bae W-K, Shim H-J, Hwang J-E, Park I-K, Chung I-J. Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-\u03b1\u2013TAK1\u2013MMP9 axis. Cell Death Discovery. 2023;9:122.","journal-title":"Cell Death Discovery"},{"key":"7905_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.omto.2020.11.004","volume":"20","author":"L Guo","year":"2021","unstructured":"Guo L, Cui J, Wang H, Medina R, Zhang S, Zhang X, Zhuang Z, Lin Y. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways. Mol Therapy-Oncolytics. 2021;20:119\u201331.","journal-title":"Mol Therapy-Oncolytics"},{"key":"7905_CR63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.37796\/2211-8039.1408","volume":"13","author":"C-W Fang","year":"2023","unstructured":"Fang C-W, Yang J-S, Chiang J-H, Shieh P-C, Tsai F-J, Tsai C-W. Chang W-S: Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis. Biomedicine. 2023;13:14.","journal-title":"Biomedicine"},{"key":"7905_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/mmr.2020.11725","volume":"23","author":"Y-H Chen","year":"2021","unstructured":"Chen Y-H, Yang S-F, Yang C-K, Tsai H-D, Chen T-H, Chou M-C, Hsiao Y-H. Metformin induces apoptosis and inhibits migration by activating the AMPK\/p53 axis and suppressing PI3K\/AKT signaling in human cervical cancer cells. Mol Med Rep. 2021;23:88.","journal-title":"Mol Med Rep"},{"key":"7905_CR65","doi-asserted-by":"crossref","unstructured":"Abdolvand M, Abadi MSS, Soltani A, Banisharif F, Ghatrehsamani M. Chronic treatment with TNF-\u03b1, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer. Heliyon. 2023;9.","DOI":"10.1016\/j.heliyon.2023.e21060"},{"key":"7905_CR66","doi-asserted-by":"publisher","first-page":"2100149","DOI":"10.1002\/adhm.202100149","volume":"10","author":"Z Song","year":"2021","unstructured":"Song Z, Luo W, Zheng H, Zeng Y, Wang J, Chen T. Translational nanotherapeutics reprograms immune microenvironment in malignant pleural effusion of lung adenocarcinoma. Adv Healthc Mater. 2021;10:2100149.","journal-title":"Adv Healthc Mater"},{"key":"7905_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jff.2018.03.024","volume":"45","author":"W Li","year":"2018","unstructured":"Li W, Wang J, Hu H, Li Q, Liu Y, Wang K. Functional polysaccharide Lentinan suppresses human breast cancer growth via inducing autophagy and caspase-7-mediated apoptosis. J Funct Foods. 2018;45:75\u201385.","journal-title":"J Funct Foods"},{"key":"7905_CR68","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","volume":"20","author":"S Nath","year":"2014","unstructured":"Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med. 2014;20:332\u201342.","journal-title":"Trends Mol Med"},{"key":"7905_CR69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12935-022-02523-z","volume":"22","author":"A Hosseinzadeh","year":"2022","unstructured":"Hosseinzadeh A, Merikhian P, Naseri N, Eisavand MR, Farahmand L. MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer Cell Int. 2022;22:110.","journal-title":"Cancer Cell Int"},{"key":"7905_CR70","doi-asserted-by":"publisher","first-page":"pkab066","DOI":"10.1093\/jncics\/pkab066","volume":"5","author":"PJ Goodwin","year":"2021","unstructured":"Goodwin PJ, Dowling RJ, Ennis M, Chen BE, Parulekar WR, Shepherd LE, Gelmon KA, Whelan TJ, Ligibel JA, Hershman DL. Cancer antigen 15\u2009\u2013\u20093\/Mucin 1 levels in CCTG MA. 32: a breast cancer randomized trial of metformin vs placebo. JNCI cancer Spectr. 2021;5:pkab066.","journal-title":"JNCI cancer Spectr"},{"key":"7905_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1158\/0008-5472.CAN-17-1636","volume":"78","author":"T Maeda","year":"2018","unstructured":"Maeda T, Hiraki M, Jin C, Rajabi H, Tagde A, Alam M, Bouillez A, Hu X, Suzuki Y, Miyo M. MUC1-C induces PD-L1 and immune evasion in triple-negative breast cancer. Cancer Res. 2018;78:205\u201315.","journal-title":"Cancer Res"},{"key":"7905_CR72","doi-asserted-by":"publisher","first-page":"1605488","DOI":"10.3389\/fimmu.2025.1605488","volume":"16","author":"X Niu","year":"2025","unstructured":"Niu X, Zhang P, Liu Z, Tang Y, Xu S, Wan X, Xu Z, Zhang G. Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation. Front Immunol. 2025;16:1605488.","journal-title":"Front Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07905-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:02:28Z","timestamp":1778097748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07905-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7905"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07905-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were conducted in strict accordance with the ethical guidelines and standards set by the Laboratory Animal Center of Shahrekord University of Medical Sciences, Shahrekord, Iran (IR.SKUMS.AEC.1403.061 and IR.SKUMS.AEC.1403.062). A total of 40 mice were used in this research, housed under controlled environmental conditions with a 12-hour light\/dark cycle and fed according to institutional guidelines. At the end of the study, all mice were sacrificed in accordance with approved ethical protocols to minimize suffering. All procedures fully complied with the ethical standards for the care and use of laboratory animals, including the ARRIVE guidelines and the NIH Guide for the Care and Use of Laboratory Animals. The procedures also followed the guidelines provided by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to declare in this manuscript, and Francesco M. Marincola serves as the Editor in Chief of the Journal of Translational Medicine.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"637"}}